Arguments that stem cells (like genes) are products of nature
and unpatentable are wending their way through the federal courts with potentially significant repercussions for the stem cell industry
Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.